JNBA Financial Advisors Sells 443 Shares of Aflac Incorporated (NYSE:AFL)

JNBA Financial Advisors reduced its stake in shares of Aflac Incorporated (NYSE:AFL) by 0.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 217,892 shares of the financial services provider’s stock after selling 443 shares during the quarter. Aflac accounts for 2.5% of JNBA Financial Advisors’ holdings, making the stock its 9th biggest holding. JNBA Financial Advisors’ holdings in Aflac were worth $24,360,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Y.D. More Investments Ltd acquired a new position in Aflac in the second quarter valued at approximately $25,000. Catalyst Capital Advisors LLC bought a new position in Aflac in the 3rd quarter valued at about $51,000. Valued Wealth Advisors LLC grew its holdings in Aflac by 116.7% during the third quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock worth $54,000 after buying an additional 258 shares in the last quarter. Fairscale Capital LLC purchased a new stake in shares of Aflac in the second quarter valued at about $54,000. Finally, Cedar Wealth Management LLC purchased a new stake in Aflac in the 1st quarter valued at about $50,000. 67.44% of the stock is owned by institutional investors.

Aflac Trading Up 1.8 %

NYSE AFL traded up $1.87 during trading on Wednesday, hitting $107.43. 650,772 shares of the company’s stock traded hands, compared to its average volume of 2,232,253. The firm has a market cap of $60.16 billion, a P/E ratio of 15.89, a PEG ratio of 2.07 and a beta of 0.96. The stock has a fifty day moving average of $110.42 and a two-hundred day moving average of $98.25. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.08 and a quick ratio of 0.10. Aflac Incorporated has a 12-month low of $75.07 and a 12-month high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $2.16 EPS for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a return on equity of 16.34% and a net margin of 22.02%. The business had revenue of $2.95 billion for the quarter, compared to analysts’ expectations of $4.30 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business’s quarterly revenue was down 40.4% on a year-over-year basis. As a group, sell-side analysts expect that Aflac Incorporated will post 7.05 EPS for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 annualized dividend and a dividend yield of 1.86%. Aflac’s dividend payout ratio (DPR) is presently 30.12%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the company. UBS Group boosted their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Citigroup boosted their target price on shares of Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Evercore ISI lifted their price target on shares of Aflac from $84.00 to $90.00 and gave the stock an “underperform” rating in a report on Thursday, September 26th. Bank of America increased their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Finally, Piper Sandler upped their price target on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $97.93.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.